BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 21569004)

  • 1. Guidelines for the diagnosis and management of multiple myeloma 2011.
    Bird JM; Owen RG; D'Sa S; Snowden JA; Pratt G; Ashcroft J; Yong K; Cook G; Feyler S; Davies F; Morgan G; Cavenagh J; Low E; Behrens J;
    Br J Haematol; 2011 Jul; 154(1):32-75. PubMed ID: 21569004
    [No Abstract]   [Full Text] [Related]  

  • 2. Thalidomide-dexamethasone as induction therapy before autologous stem cell transplantation in patients with newly diagnosed multiple myeloma and renal insufficiency.
    Tosi P; Zamagni E; Tacchetti P; Ceccolini M; Perrone G; Brioli A; Pallotti MC; Pantani L; Petrucci A; Baccarani M; Cavo M
    Biol Blood Marrow Transplant; 2010 Aug; 16(8):1115-21. PubMed ID: 20197100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Guidelines for the diagnosis and management of multiple myeloma by the Japan Myeloma Study Group].
    Shimizu K;
    Rinsho Ketsueki; 2005 Jun; 46(6):424-32. PubMed ID: 16447724
    [No Abstract]   [Full Text] [Related]  

  • 4. NCCN: Multiple myeloma.
    Traynor AE; Noga SJ;
    Cancer Control; 2001; 8(6 Suppl 2):78-87. PubMed ID: 11760563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [New treatment strategies for multiple myeloma].
    Ozaki S
    Rinsho Ketsueki; 2009 Oct; 50(10):1506-17. PubMed ID: 19915360
    [No Abstract]   [Full Text] [Related]  

  • 6. [Treatment for multiple myeloma: current status and future strategy in Japan].
    Iida S
    Rinsho Ketsueki; 2008 Oct; 49(10):1368-73. PubMed ID: 18833921
    [No Abstract]   [Full Text] [Related]  

  • 7. Diagnosis and management of multiple myeloma.
    UK myeloma forum. British Committee for Standards in Haematology
    Br J Haematol; 2001 Dec; 115(3):522-40. PubMed ID: 11736932
    [No Abstract]   [Full Text] [Related]  

  • 8. Tandem autologous stem cell transplantation for multiple myeloma: is it applicable and effective outside clinical trials?
    Dimopoulos MA
    Haematologica; 2005 Dec; 90(12):1588. PubMed ID: 16330425
    [No Abstract]   [Full Text] [Related]  

  • 9. [Multiple myeloma of the bone].
    Facon T
    Rev Prat; 2002 Jan; 52(1):63-70. PubMed ID: 11852769
    [No Abstract]   [Full Text] [Related]  

  • 10. [Diagnosis and therapy of multiple myeloma: current aspects].
    Betticher DC; Cerny T; Fey MF
    Schweiz Med Wochenschr; 1995 Mar; 125(11):541-51. PubMed ID: 7899848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple myeloma. Part II: Treatment.
    Varet B; Choukroun G; Grünfeld JP
    Nephron; 1995; 70(1):18-20. PubMed ID: 7542366
    [No Abstract]   [Full Text] [Related]  

  • 12. Randomized comparison of granulocyte colony-stimulating factor versus granulocyte-macrophage colony-stimulating factor plus intensive chemotherapy for peripheral blood stem cell mobilization and autologous transplantation in multiple myeloma.
    Arora M; Burns LJ; Barker JN; Miller JS; Defor TE; Olujohungbe AB; Weisdorf DJ
    Biol Blood Marrow Transplant; 2004 Jun; 10(6):395-404. PubMed ID: 15148493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Guidelines on the diagnosis and management of multiple myeloma 2005.
    Smith A; Wisloff F; Samson D; ; ;
    Br J Haematol; 2006 Feb; 132(4):410-51. PubMed ID: 16412016
    [No Abstract]   [Full Text] [Related]  

  • 14. [Multiple myeloma].
    Peest D
    Ther Umsch; 1996 Feb; 53(2):147-51. PubMed ID: 8629265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Supportive therapy in multiple myeloma.
    Ludwig H; Zojer N
    Recent Results Cancer Res; 2011; 183():307-33. PubMed ID: 21509692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complete remission of multiple myeloma.
    Lonial S
    Clin Adv Hematol Oncol; 2007 Sep; 5(9):671-2, 675. PubMed ID: 17982407
    [No Abstract]   [Full Text] [Related]  

  • 17. [Multiple myeloma--new therapeutic perspectives].
    Skotnicki AB; Wolska-Smoleń T; Jurczyszyn A
    Przegl Lek; 1999; 56 Suppl 1():67-72. PubMed ID: 10494186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early chemosensitivity to VAD regimen predicts a favorable outcome after autologous stem cell transplantation in multiple myeloma.
    Patriarca F; Sperotto A; Filì C; Zaja F; Prosdocimo S; Fanin R
    Haematologica; 2002 Jul; 87(7):779-81. PubMed ID: 12091134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Complete remission of nephrotic syndrome and improvement of renal function in a patient with light chain deposition disease following high dose chemotherapy with transplantation of autologous haematopoietic stem cells. A case study and review of literature].
    Adam Z; Krejcí M; Pour L; Stepánková S; Cermáková Z; Voska L; Teplan V; Krivanová A; Hájek R; Mayer J
    Vnitr Lek; 2009 Nov; 55(11):1089-96. PubMed ID: 20017442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple myeloma.
    Smith D; Yong K
    BMJ; 2013 Jun; 346():f3863. PubMed ID: 23803862
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 19.